The dsRNA protein kinase PKR:: Virus and cell control

被引:493
作者
Garcia, M. A.
Meurs, E. F.
Esteban, M.
机构
[1] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, E-28049 Madrid, Spain
[2] Inst Pasteur, Hepacivirus, F-75724 Paris 15, France
关键词
protein kinase; PKR; dsRNA-dependent enzyme; antiviral; anticellular; translational control; signal transduction; modulation; apoptosis;
D O I
10.1016/j.biochi.2007.03.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The IFN-induced double-stranded RNA-dependent protein kinase (PKR) is one of the four mammalian serine-threonine kinases (the three others being HRL GCN2 and PERK) that phosphorylate the eIF2 alpha translation initiation factor, in response to stress signals, mainly as a result of viral infections. eIF2 alpha. phosphorylation results in arrest of translation of both cellular and viral mRNAs, an efficient way to inhibit virus replication. The particularity of PKR is to activate by binding to dsRNA through two N terminal dsRNA binding motifs (dsRBM). PKR activation during a viral infection represents a threat for several viruses, which have therefore evolved to express PKR inhibitors, such as the Vaccinia E3L and K3L proteins. The function of PKR can also be regulated by cellular proteins, either positively (RAX/PACT; Mda7) or negatively (p581PK, TRBP. nucleophosmin, Hsp90/70). PKR can provoke apoptosis, in part through its ability to control protein translation, but the situation appears to be more complex. as NF-kappa B, ATF-3 and p53 have also been implicated. PKR-induced apoptosis involves mainly the FADD/caspase 8 pathway, while the mitochondrial APAF/caspase 9 pathway is also engaged. As a consequence of the effects of PKR on translation, transcription and apoptosis. PKR can function to control cell growth and cell differentiation, and its activity can be controlled by the action of several oncogenes. (C) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:799 / 811
页数:13
相关论文
共 207 条
[81]   TAT-RESPONSIVE REGION RNA OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STIMULATES PROTEIN-SYNTHESIS INVIVO AND INVITRO - RELATIONSHIP BETWEEN STRUCTURE AND FUNCTION [J].
GUNNERY, S ;
GREEN, SR ;
MATHEWS, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) :11557-11561
[82]   TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing [J].
Haase, AD ;
Jaskiewicz, L ;
Zhang, HD ;
Lainé, S ;
Sack, R ;
Gatignol, A ;
Filipowicz, W .
EMBO REPORTS, 2005, 6 (10) :961-967
[83]   The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis [J].
Hai, T ;
Hartman, MG .
GENE, 2001, 273 (01) :1-11
[84]   Expression of the double-stranded RNA-dependent protein kinase (p68) in human breast tissues [J].
Haines, GK ;
Cajulis, R ;
Hayden, R ;
Duda, R ;
Talamonti, M ;
Radosevich, JA .
TUMOR BIOLOGY, 1996, 17 (01) :5-12
[85]   Interferon-responsive protein kinase (p68) and proliferating cell nuclear antigen are inversely distributed in head and neck squamous cell carcinoma [J].
Haines, GK ;
Panos, RJ ;
Bak, PM ;
Brown, T ;
Zielinski, M ;
Leyland, J ;
Radosevich, JA .
TUMOR BIOLOGY, 1998, 19 (01) :52-59
[86]   Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells [J].
Hatada, E ;
Saito, S ;
Fukuda, R .
JOURNAL OF VIROLOGY, 1999, 73 (03) :2425-2433
[87]  
Haus Olga, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P95
[88]   The γ134.5 protein of herpes simplex virus 1 has the structural and functional attributes of a protein phosphatase I regulatory subunit and is present in a high molecular weight complex with the enzyme in infected cells [J].
He, B ;
Gross, M ;
Roizman, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) :20737-20743
[89]  
HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441
[90]   Loss of PKR activity in chronic lymphocytic leukemia [J].
Hii, SI ;
Hardy, L ;
Crough, T ;
Payne, EJ ;
Grimmett, K ;
Gill, D ;
McMillan, NAJ .
INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (03) :329-335